Category: 6. Business

The convergence of artificial intelligence (AI) and life sciences is no longer a distant promise. Companies operating in the sector are actively embracing the technology and are already achieving measurable results. In the following exclusive…

Introduction

Digital health interventions (DHIs) including web-based and mobile health (mHealth) interventions can improve clinical outcomes for chronic health conditions. DHIs apply behavior change theories with variable mechanisms of action,…

Jamie Dimon, the boss of JP Morgan, has said artificial intelligence “may go too fast for society” and cause “civil unrest” unless governments and business support displaced workers.

While advances in AI will have huge benefits, from…

Introduction

Background

Daytime sleepiness is an important, yet understudied, dimension of adolescents’ sleep health []. Its prevalence varies widely across countries, ranging from 7.8% to 55.8% [], and it is notably higher in adolescence than in…

The Gates Foundation and OpenAI have announced a $50 million initiative, Horizon1000, to harness artificial intelligence (AI) for strengthening primary health care across African countries, starting in Rwanda, according to Reuters.¹ The…

On January 20, 2026, the U.S. Food and Drug Administration (FDA) released a draft guidance for industry regarding the use of measurable residual disease and complete response as primary endpoints in clinical trials evaluating drugs and…

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any…